Latest News and Press Releases

Hamilton, March 07, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (OTCQB:CYTOF) today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for a...

Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...

Gulf Breeze, FL, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading innovator in sexual health solutions, is thrilled to announce the release of its groundbreaking PT-141 nasal spray,...

Gulf Breeze, FL, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading innovator in the field of biohacking and cognitive enhancement, is proud to announce the launch of its groundbreaking...

Insignis Therapeutics advances IN-001, a needle-free anaphylaxis treatment, following FDA’s positive feedback and Fast Track designation.

Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Over the Counter (OTC) Drugs - Market Insight, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...

Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "United States Over-The-Counter Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024-2029)" report has been added to ...

Insignis' Phase 1 trial shows IN-001 spray quickly reaches target epinephrine levels, sustained for 2 hours, offering a reliable needle-free alternative.

Hamilton, Bermuda, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Nuance Pharma successfully launched Bentrio® nasal spray for protection against airborne particles in Hong Kong and filed request for marketing...

Hamilton, Bermuda, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Successful launch of Bentrio by Pharma Nordic AS in Norway in 2024Exclusive distribution agreement extended to also include Sweden and Denmark ...